India Extends Deadline For Imposition Of Higher Import Duties On 29 U.S. Products Â
For the third time since August, India extended the deadline for the imposition of higher customs duties on 29 U.S. products.
The duties will come into effect from Dec. 17, the government said on Thursday. The commerce ministry had asked its finance counterpart to further push the deadline for the roll-out of duty hike. In June, India decided to impose retaliatory tariffs from Aug. 4. But it was extended by another 45 days till Sept.18 and then again till Nov. 2.
As part of imposition of higher import duties, New Delhi has notified higher tariffs on several products.
- Import duty on walnuts is set to be hiked to 120 percent from the current 30 percent tariff.
- Duty on chickpeas, Bengal gram (chana) and masur dal will be hiked to 70 percent from 30 percent.
- Levy on lentils will be hiked to 40 percent from 30 percent.
Other products which would attract higher duties include boric acid, phosphoric acid, diagnostic reagent, flat rolled products of iron, certain flat rolled products of stainless steel. The duty hike move by India was in retaliation to U.S. President Donald Trump's March 9 decision to impose heavy tariffs on imported steel and aluminium items.
Senior officials of India and the U.S. are in discussions to finalise a kind of trade deal. Both the sides hold two track discussions -- to increase trade in short and medium term, and identify long term trade potentials.
Meanwhile, the U.S. on Thursday ended duty-free concessions on import of about 50 Indian products, mostly from the handloom and agriculture sectors. These goods enjoyed a duty-free access to the U.S. market under the generalized system of preferences.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.